Briefly, tumor cell-derived factors (e.g., parathyroid hormone-related protein (PTHrP) and interleukin 11 (IL-11)) alter the RANKL/OPG ratio in favor of osteoclast activity [21,22]. The gene discussed is PTHLH; the disease is neoplasm.